KAYLA WALKER: Open Payments
NPI 1831863463 · OZARK, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,299 in 136 payments from 20 companies in 2025. Trend: 2023 $702 · 2024 $1,257 · 2025 $2,299
Food & beverage: $2,299
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 25 | $518 |
| Axsome Therapeutics, Inc. | 14 | $277 |
| Novo Nordisk Inc | 13 | $218 |
| ABBVIE INC. | 17 | $210 |
| PFIZER INC. | 12 | $185 |
| Lilly USA, LLC | 10 | $147 |
| Takeda Pharmaceuticals U.S.A., Inc. | 12 | $141 |
| Dexcom, Inc. | 4 | $87 |
| Otsuka America Pharmaceutical, Inc. | 4 | $82 |
| GlaxoSmithKline, LLC. | 4 | $65 |
Products named: BREZTRI, Auvelity, Ozempic, FARXIGA, TRINTELLIX, REXULTI, NURTEC ODT, MOUNJARO.
Industry payments across MO — which companies pay providers there.
